baicalin has been researched along with Skin Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Li, X; Song, S; Wang, Y; Zhu, J | 1 |
| Sahebkar, A | 1 |
1 review(s) available for baicalin and Skin Diseases
| Article | Year |
|---|---|
Baicalin as a potentially promising drug for the management of sulfur mustard induced cutaneous complications: a review of molecular mechanisms.
Topics: Calcium Signaling; Chemical Warfare Agents; DNA Damage; Flavonoids; Humans; Inflammation; Matrix Metalloproteinases; Mitogen-Activated Protein Kinases; Mustard Gas; Nitric Oxide; Oxidative Stress; Quality of Life; Skin Diseases | 2012 |
1 other study(ies) available for baicalin and Skin Diseases
| Article | Year |
|---|---|
Potential mechanism of oral baicalin treating psoriasis via suppressing Wnt signaling pathway and inhibiting Th17/IL-17 axis by activating PPARĪ³.
Topics: Animals; Disease Models, Animal; Estrogens; Flavonoids; Imiquimod; Interleukin-17; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; PPAR gamma; Protein Kinases; Psoriasis; Skin; Skin Diseases; Th17 Cells; Tumor Necrosis Factor-alpha; Wnt Signaling Pathway | 2022 |